Does iron overload really matter in stem cell transplantation?
Open Access
- 12 March 2012
- journal article
- research article
- Published by Wiley in American Journal of Hematology
- Vol. 87 (6), 569-572
- https://doi.org/10.1002/ajh.23188
Abstract
A growing body of evidence suggests that iron overload is associated with inferior outcomes after myeloablative allogeneic hematopoietic stem cell transplantation (HSCT). However, all of those studies used surrogate markers of iron overload, especially serum ferritin, and most had a retrospective design. We conducted a prospective observational study in patients with myelodysplastic syndrome or acute leukemia undergoing myeloablative HSCT. Forty‐five patients who were followed for over 1 year, with serial measurements of serum iron parameters, as well as liver and cardiac magnetic resonance imaging. There was no significant increase in ferritin, liver or cardiac iron content in the 12 months following HSCT. Although serum ferritin still appeared to have prognostic significance, as previously reported, pre‐HSCT iron overload (as reflected in liver iron content) was not associated with increased mortality, relapse, or graft‐versus‐host disease. These results raise the possibility that the adverse prognostic impact of pre‐HSCT hyperferritinemia may be related to factors independent of iron overload. Am. J. Hematol. 87:569–572, 2012.Keywords
This publication has 31 references indexed in Scilit:
- Classifying Cytogenetics in Patients with Acute Myelogenous Leukemia in Complete Remission Undergoing Allogeneic Transplantation: A Center for International Blood and Marrow Transplant Research StudyTransplantation and Cellular Therapy, 2011
- Increased Serum Iron Levels and Infectious Complications after Liver TransplantationClinical Infectious Diseases, 2010
- Prognostic impact of pre-transplantation transfusion history and secondary iron overload in patients with myelodysplastic syndrome undergoing allogeneic stem cell transplantation: a GITMO studyHaematologica, 2009
- The transplant iron score as a predictor of stem cell transplant survivalJournal of Hematology & Oncology, 2009
- Multicenter validation study of a transplantation-specific cytogenetics grouping scheme for patients with myelodysplastic syndromesBone Marrow Transplantation, 2009
- Effect of iron overload and iron-chelating therapy on allogeneic hematopoietic SCT in childrenBone Marrow Transplantation, 2009
- Red Blood Cell Transfusion Dependence and Outcome after Allogeneic Peripheral Blood Stem Cell Transplantation in Patients with de Novo Myelodysplastic Syndrome (MDS)Transplantation and Cellular Therapy, 2008
- Pretreatment C-Reactive Protein Is a Predictor for Outcomes after Reduced-Intensity Allogeneic Hematopoietic Cell TransplantationTransplantation and Cellular Therapy, 2008
- Prognostic impact of elevated pretransplantation serum ferritin in patients undergoing myeloablative stem cell transplantationBlood, 2007
- Iron overload might increase transplant-related mortality in haematopoietic stem cell transplantationBone Marrow Transplantation, 2002